Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Nida Hanif, Ammara Zamir, Imran Imran, Hamid Saeed, Abdul Majeed, Anees ur Rehman, Waseem Ashraf, Faleh Alqahtani & Muhammad Fawad Rasool. (2023) Clinical pharmacokinetics of nebivolol: a systematic review. Drug Metabolism Reviews 55:4, pages 428-440.
Read now
Read now
Zahide Cavdar, Ayse Kocak, Cemre Ural, Aysan Afagh, Sibel Ersan, Seda Ozbal, Merve Tatli, Asli Celik, Sevki Arslan & Caner Cavdar. (2023) Role of p38 MAPK, Akt and NFκB in renoprotective effects of nebivolol on renal ischemia-reperfusion injury in rats. Biotechnic & Histochemistry 98:6, pages 401-411.
Read now
Read now
Yan Wang & Xiushan Dong. (2016) Nebivolol ameliorates asymmetric dimethylarginine-induced vascular response in rat aorta via β3 adrenoceptor-mediated mechanism. Clinical and Experimental Hypertension 38:2, pages 252-259.
Read now
Read now
Burak Veli Ulger, Halil Erbis, Gul Turkcu, Aysun Ekinci, Mehmet Akif Turkoglu, Cenap Ekinci, Vural Taner Yilmaz & Bilsel Bac. (2015) Nebivolol Ameliorates Hepatic Ischemia/Reperfusion Injury on Liver But Not on Distant Organs. Journal of Investigative Surgery 28:5, pages 245-252.
Read now
Read now
Articles from other publishers (45)
Łukasz Wołowiec, Grzegorz Grześk, Joanna Osiak, Aleksandra Wijata, Martyna Mędlewska, Patryk Gaborek, Joanna Banach, Anna Wołowiec & Mariola Głowacka. (2023) Beta-blockers in cardiac arrhythmias–Clinical pharmacologist’s point of view. Frontiers in Pharmacology 13.
Crossref
Crossref
Andrea Saavedra-Alvarez, Katherine V. Pereyra, Camilo Toledo, Rodrigo Iturriaga & Rodrigo Del Rio. (2022) Vascular dysfunction in HFpEF: Potential role in the development, maintenance, and progression of the disease. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
P. V. Moskaleva, M. A. Khramchenko, A. D. Karpenkova, M. M. Petrova & N. A. Shnayder. (2022) Modern concepts about pathogenesis of the tension-type headache and mechanisms of development of the tension-type headache and arterial hypertension phenotype. Russian neurological journal 27:2, pages 22-33.
Crossref
Crossref
Maria Alessandra Gammone, Konstantinos Efthymakis & Nicolantonio D’Orazio. (2021) Effect of Third-Generation Beta Blockers on Weight Loss in a Population of Overweight-Obese Subjects in a Controlled Dietary Regimen. Journal of Nutrition and Metabolism 2021, pages 1-7.
Crossref
Crossref
Shulin Li, Fei Wang & Dong Sun. (2021) The renal microcirculation in chronic kidney disease: novel diagnostic methods and therapeutic perspectives. Cell & Bioscience 11:1.
Crossref
Crossref
Iosif Z. Shubitidze & Vitalii G. Tregubov. (2021) Effects of the b-blockers on the functional state of patients with ventricular arrhythmias. Systemic Hypertension 18:1, pages 19-24.
Crossref
Crossref
Natalia A. Shnayder, Marina M. Petrova, Polina V. Moskaleva, Pavel A. Shesternya, Elena A. Pozhilenkova & Regina F. Nasyrova. (2021) The Role of Single-Nucleotide Variants of NOS1, NOS2, and NOS3 Genes in the Comorbidity of Arterial Hypertension and Tension-Type Headache. Molecules 26:6, pages 1556.
Crossref
Crossref
K. Uma priya, Ch. Venkataramaiah, N. Y. Sreedhar & C. Naga Raju. (2021)
Design, synthesis, characterization and
in vitro, in vivo
and
in silico
antimicrobial and antiinflammatory activities of a new series of sulphonamide and carbamate derivatives of a nebivolol intermediate
. RSC Advances 11:7, pages 3897-3916.
Crossref
Crossref
Sugandh Kumar, Bharati Singh, Pratima Kumari, Preethy V. Kumar, Geetanjali Agnihotri, Shaheerah Khan, Tushar Kant Beuria, Gulam Hussain Syed & Anshuman Dixit. (2021) Identification of multipotent drugs for COVID-19 therapeutics with the evaluation of their SARS-CoV2 inhibitory activity. Computational and Structural Biotechnology Journal 19, pages 1998-2017.
Crossref
Crossref
Sabri Colak, Beril Gurlek, Atilla Topcu, Levent Tumkaya, Tolga Mercantepe & Adnan Yilmaz. (2020) Protective effects of nebivolol on ovarian ischemia–reperfusion injury in rat. Journal of Obstetrics and Gynaecology Research 46:11, pages 2407-2416.
Crossref
Crossref
Iosif Z. Shubitidze & Vitalii G. Tregubov. (2020) Assessment of the effect of -blockers on the functional state in patients with ventricular arrhythmias: results of a comparative study. CardioSomatics 11:2, pages 23-27.
Crossref
Crossref
Kazuo Yamagata & Yukio Yamori. (2020) Inhibition of Endothelial Dysfunction by Dietary Flavonoids and Preventive Effects Against Cardiovascular Disease. Journal of Cardiovascular Pharmacology 75:1, pages 1-9.
Crossref
Crossref
Armin Sebastian Guntner, Bernhard Thalhamer, Christian Klampfl & Wolfgang Buchberger. (2019) Collision cross sections obtained with ion mobility mass spectrometry as new descriptor to predict blood-brain barrier permeation by drugs. Scientific Reports 9:1.
Crossref
Crossref
M.E.R. Alebrante, M.M. Dias, C.A. Neves, D.D. Rosa, N.P. Siqueira, A.J. Natali & M.C.G. Peluzio. (2018) Effects of exercise training and nebivolol treatment on atherosclerotic plaque development, iNOS expression and antioxidant capacity in apoE −/− mice. Science & Sports 33:2, pages 106-113.
Crossref
Crossref
V. G. Tregubov, Iosif Z. Shubitidze, S. G. Kanorskii & V. M. Pokrovsky. (2018) The results of a comparative study effectiveness of therapy with nebivolol and sotalol in patients with ventricular arrhythmias.. Clinical Medicine (Russian Journal) 95:11, pages 1050-1056.
Crossref
Crossref
Ercan Yuvanc, Devrim Tuglu, Tunc Ozan, Ucler Kisa, Mahi Balci, Ertan Batislam & Erdal Yilmaz. (2018) Investigation of the antioxidant effects of pheniramine maleate and nebivolol on testicular damage in rats with experimentally induced testis torsion. Acta Cirurgica Brasileira 33:2, pages 125-133.
Crossref
Crossref
Elisa Alberton Haas, Marcelo Nishiyama & Protásio Lemos da Luz. 2018. Endothelium and Cardiovascular Diseases. Endothelium and Cardiovascular Diseases
683
697
.
Fernanda Marciano Consolim-Colombo & Luiz Aparecido Bortolotto. 2018. Endothelium and Cardiovascular Diseases. Endothelium and Cardiovascular Diseases
429
437
.
A Coats & S Jain. (2017) Protective effects of nebivolol from oxidative stress to prevent hypertension-related target organ damage. Journal of Human Hypertension 31:6, pages 376-381.
Crossref
Crossref
Mazhar Hussain, Muhammad Saeed, Muhammad Zafar Majeed Babar, Moazzam Ali Atif & Lubna Akhtar. (2017) Nebivolol Attenuates Neutrophil Lymphocyte Ratio: A Marker of Subclinical Inflammation in Hypertensive Patients. International Journal of Hypertension 2017, pages 1-6.
Crossref
Crossref
Wafaa A. Hewedy & Dalia K. Mostafa. (2016) Nebivolol suppresses asymmetric dimethylarginine and attenuates cyclosporine-induced nephrotoxicity and endothelial dysfunction in rats. Pharmacological Reports 68:6, pages 1319-1325.
Crossref
Crossref
Zhen TanZhichao Xiao, Jinhong Wei, Jingqun ZhangQiang ZhouChris D. Smith, Alma NaniGuogen WuLong-Sheng SongThomas G. Back, Michael FillS. R. Wayne Chen. (2016) Nebivolol suppresses cardiac ryanodine receptor-mediated spontaneous Ca2+ release and catecholaminergic polymorphic ventricular tachycardia. Biochemical Journal 473:22, pages 4159-4172.
Crossref
Crossref
I. Z. Shubitidze, V. G. Tregubov & V. M. Pokrovsky. (2016) COMPARE THE EFFECTIVENESS OF NEBIVOLOL AND SOTALOL IN PATIENTS WITH HYPERTENSIVE DISEASE AND VENTRICULAR ARRHYTHMIAS. Eurasian heart journal:3, pages 14-21.
Crossref
Crossref
Burak V Ulger, Murat Kapan, Omer Uslukaya, Zubeyir Bozdag, Ahmet Turkoglu, Ulas Alabalık & Akın Onder. (2016) Comparing the effects of nebivolol and dexpanthenol on wound healing: an experimental study. International Wound Journal 13:3, pages 367-371.
Crossref
Crossref
Fateme Shamekhi Amiri. (2016) Recent advances in the treatment of renal diseases with nebivolol: A literature review. Néphrologie & Thérapeutique 12:3, pages 140-148.
Crossref
Crossref
Pramod Reddy & Lori Dupree. (2016) Approach to Antihypertensive Therapy. American Journal of Therapeutics 23:2, pages e451-e473.
Crossref
Crossref
Cheol-Ho Kim, Nelson Abelardo, Peera Buranakitjaroen, Rungroj Krittayaphong, Chin Hock Lim, Sung-Ha Park, Nguyen Vinh Pham, Gregorio Rogelio, Bernard Wong & Lip Ping Low. (2016) Hypertension treatment in the Asia-Pacific: the role of and treatment strategies with nebivolol. Heart Asia 8:1, pages 22-26.
Crossref
Crossref
Branislava Ivanovic & Marijana Tadic. (2015) Hypercholesterolemia and Hypertension: Two Sides of the Same Coin. American Journal of Cardiovascular Drugs 15:6, pages 403-414.
Crossref
Crossref
Frank H. Mose, Janni M. Jensen, Safa Therwani, Jesper Mortensen, Annebirthe B. Hansen, Jesper N. Bech & Erling B. Pedersen. (2015) Effect of nebivolol on renal nitric oxide availability and tubular function in patients with essential hypertension. British Journal of Clinical Pharmacology 80:3, pages 425-435.
Crossref
Crossref
Filip Y. Fisker, Daniela Grimm & Markus Wehland. (2015) Third-Generation Beta-Adrenoceptor Antagonists in the Treatment of Hypertension and Heart Failure. Basic & Clinical Pharmacology & Toxicology 117:1, pages 5-14.
Crossref
Crossref
Icilma V. Fergus, Kenneth L. Connell & Keith C. Ferdinand. (2015) A Comparison of Vasodilating and Non-vasodilating Beta-Blockers and Their Effects on Cardiometabolic Risk. Current Cardiology Reports 17:6.
Crossref
Crossref
Csaba András Dézsi. (2015) The role of β-blockers in patients with metabolic syndrome and hypertension. Orvosi Hetilap 156:16, pages 623-625.
Crossref
Crossref
Mei-Ling Yeh, Yu-Chun Chang, Yi-Ying Huang & Tso-Ying Lee. (2015) A randomized controlled trial of auricular acupressure in heart rate variability and quality of life for hypertension. Complementary Therapies in Medicine 23:2, pages 200-209.
Crossref
Crossref
Sae Mi Yoo, Sung Hyun Choi, Monica Dha Yea Jung, Sung Cil Lim & Sang Hong Baek. (2014) Short-term use of telmisartan attenuates oxidation and improves Prdx2 expression more than antioxidant β-blockers in the cardiovascular systems of spontaneously hypertensive rats. Hypertension Research 38:2, pages 106-115.
Crossref
Crossref
C.H. Santuzzi, R.V. Tiradentes, V. Mengal, E.R.G. Claudio, H. Mauad, S.A. Gouvea & G.R. Abreu. (2015) Combined aliskiren and L-arginine treatment has antihypertensive effects and prevents vascular endothelial dysfunction in a model of renovascular hypertension. Brazilian Journal of Medical and Biological Research 48:1, pages 65-76.
Crossref
Crossref
C. Briciu, M. Neag, D. Muntean, L. Vlase, C. Bocsan, A. Buzoianu, A.-M. Gheldiu, M. Achim & A. Popa. (2014) A pharmacokinetic drug interaction study between nebivolol and paroxetine in healthy volunteers. Journal of Clinical Pharmacy and Therapeutics 39:5, pages 535-540.
Crossref
Crossref
Figen Amber Cicek, Aysegul Toy, Erkan Tuncay, Belgin Can & Belma Turan. (2014) Beta-blocker timolol alleviates hyperglycemia-induced cardiac damage via inhibition of endoplasmic reticulum stress. Journal of Bioenergetics and Biomembranes 46:5, pages 377-387.
Crossref
Crossref
Vanessa A. Voltarelli, Luiz R.G. Bechara, Aline V.N. Bacurau, Katt C. Mattos, Paulo M.M. Dourado, Carlos R. BuenoJr.Jr., Dulce E. Casarini, Carlos E. Negrao & Patricia C. Brum. (2014)
Lack of β
2
‐adrenoceptors aggravates heart failure‐induced skeletal muscle myopathy in mice
. Journal of Cellular and Molecular Medicine 18:6, pages 1087-1097.
Crossref
Crossref
Jonathan G. Howlett. (2014) Nebivolol: Vasodilator Properties and Evidence for Relevance in Treatment of Cardiovascular Disease. Canadian Journal of Cardiology 30:5, pages S29-S37.
Crossref
Crossref
Ting-ting Yu, Kun Guo, Han-chun Chen, Chao-zong Lan, Jian Wang, Ling-ling Huang, Xing-hui Wang, Zhen Zhang & Shan Gao. (2013) Effects of traditional Chinese medicine Xin-Ji-Er-Kang formula on 2K1C hypertensive rats: role of oxidative stress and endothelial dysfunction. BMC Complementary and Alternative Medicine 13:1.
Crossref
Crossref
Carla S. Ceron, Elen Rizzi, Danielle A. Guimarães, Alisson Martins-Oliveira, Raquel F. Gerlach & Jose E. Tanus-Santos. (2013) Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension. Free Radical Biology and Medicine 65, pages 47-56.
Crossref
Crossref
Dmitriy Aleksandrovich Napalkov & Aleksandr Sergeevich Panferov. (2013) Osobennosti techeniya serdechno-sosudistykh zabolevaniy i printsipy vybora ratsional'noy antigipertenzivnoy terapii u bol'nykh khronicheskoy obstruktivnoy bolezn'yu legkikh. Systemic Hypertension 10:3, pages 77-79.
Crossref
Crossref
Chenglin Huang, Dongrui Chen, Qihai Xie, Ying Yang & Weili Shen. (2013) Nebivolol stimulates mitochondrial biogenesis in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications 438:1, pages 211-217.
Crossref
Crossref
Erkan Tuncay, Esma N. Okatan, Guy Vassort & Belma Turan. (2013) ß-Blocker Timolol Prevents Arrhythmogenic Ca2+ Release and Normalizes Ca2+ and Zn2+ Dyshomeostasis in Hyperglycemic Rat Heart. PLoS ONE 8:7, pages e71014.
Crossref
Crossref
Tao Luo, Baihe Chen, Zonglei Zhao, Nvqin He, Zhi Zeng, Bing Wu, Yasushi Fukushima, Meng Dai, Qiaobing Huang, Dingli Xu, Jianping Bin, Masafumi Kitakaze & Yulin Liao. (2013) Histamine H2 receptor activation exacerbates myocardial ischemia/reperfusion injury by disturbing mitochondrial and endothelial function. Basic Research in Cardiology 108:3.
Crossref
Crossref